Study of Bacterial L-asparaginase and Molecular expression of l-asparaginase gene in Escherichia coli
DOI:
https://doi.org/10.61841/1cvjph50Abstract
E. coli remains highly active even after it is removed from the blood, possibly by
sequestration by liver cells) the half-life of the enzyme is increased when lymphoma cells
are implanted in guinea pigs. Since then, several microorganisms were evaluated to
obtain an L-asparaginase with greater antitumor activity compared to that produced by E.
coli and that was produced in an economically viable way. It is considered that the new
L-asparaginases to be used as medication must have pharmacological activity causing
minimal side effects. Thus, it is expected that they present a high affinity for the
substrate, a half-life time sufficient to avoid administration of several doses, low
immunogenicity and high stability. It was also postulated that a low cross-glutaminolytic
activity is important to avoid excessive side effects of the enzyme treatment. Various
information can be extracted from the simulation trajectory, such as the energy of
interaction between residues from the catalytic site of an enzyme and its substrate
(intermolecular) or interactions that one or more generated mutations may have with
neighboring residues within the protein (intramolecular) .In the Total Potential Energy
equation, we can see that the first three terms refer to: the bond length, the angles
between the atoms and the bond twist, respectively. The fourth term of the equation refers
to the calculation for non-directly bonded atoms and for atoms whose interaction is
intermolecular, thus considering the van der Waals and Coulomb interactions
Downloads
References
Gomes, D. C. Biochemical and kinetic characterization of bacterial L-asparaginases and
evaluation of their cytotoxic potential, Course Conclusion Paper, Federal
University of Ceará, Fortaleza, 31 f. 2019.
Jawa, V.; Cousens, L. P.; Awwad, M.; Wakshull, E.; Kropshofer, H.;Groot, A. S. D. Tcell dependent immunogenicity of protein therapeutics: Preclinical assessment and
mitigation. Clinical Immunology, Elsevier, v. 149, p. 534–555, 2013.
Kumar, K., Verma, N., The various sources and application of L-asparaginase. Asian
Journal of Biochemical and Pharmaceutical Research, v. 2, n. 3, p. 197–205, 2012.
Lopes A. M., Oliveira-Nascimento L., De Ribeiro A., et al. Therapeutic l-asparaginase:
upstream, downstream and beyond. Crit Rev Biotechnol, v. 8551, p. 1- 18, dec.
2015.
Nelson, D.L.; COX, M.M. Lehninger's Principles of Biochemistry. 5. ed. Porto Alegre:
Artmed, 2011.
Pacheco, D.L.A. Deimmunization of L-asparaginase from Escherichia coli by Genetic
Algorithm. Course Completion Paper, Federal University of Ceará, Fortaleza, 86 f.
2019.
Salzer, W. L., Asselin, B. L., Plourde, P. V., Corn, T., Hunger SP. Development of
asparaginase Erwinia chrysanthemifor the treatmentof acute lymphoblastic
leukemia. Annals of the New York Academy of Sciences, v. 1329, p. 81–92, 2014
Shen, Y.; Maupetit, J.; Derreumaux, P.; Tuffery, P. Improved PEP-FOLD Approach for
Peptide and Miniprotein Structure Prediction. Journal of Chemical Theory and
Computation, [S.l.], v. 10, p. 4745–4758, 2014.
Verma N., Kumar K., Kaur G., Anand S. L-asparaginase: a promising chemotherapeutic
agent. Crit Rev Biotechnol, v. 27, n. 1, p. 45-62, out. 2007. Disponível em:
http://dx.doi.org/10.1080/07388550601173926.
Yao, H., Wynendaele, E., De Spiegeleer, B. Thermal sensitivity as a quality control
attribute for biotherapeutics: The L-asparaginase case. Drug Test Anal; 1–11. 2019.
Yazdi, Mehdi & Kolahi, Maryam & Foroghmand, A. & Tabandeh, Mohammad reza.
(2020). In silico assessment of plant L-asparaginase and estimating its allergenicity
in comparison to bacteria asparaginase. Pediatric Hematology/Oncology and
Immunopathology. 19. 35-46. 10.24287/1726-1708-2020-19-1-35-46.
Zhao, H.; Verma, D.; Li,W.; Choi, Y.; Ndong, C.; Fiering, S. N.; Bailey-Kellogg, C.;
Griswold, K. E. Depletion of T cell epitopes in lysostaphin mitigates anti-drug
antibody response and enhances antibacterial efficacy in vivo. Chemistry and
Biology, Elsevier, v. 22, p. 629–639, 2015.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.